Page 14 - Revista Portuguesa - SPORL - Vol 61. Nº4
P. 14

did not associate with treatment response          inflammatory burden   9,14 . However, studies are
         rates. In fact, the lack of correlation between    limited by small sample sizes, heterogeneous
         injection timing and degree of improvement         patient populations, and PRP preparation
         had similarly been reported in the randomized      and administration variations. Therefore,
         trial .  Moreover, it is known that spontaneous    more extensive and well-designed studies
             10
         recovery in post-viral olfactory dysfunction can   are  needed  to  confirm  these  findings  and
         potentially occur for longer than one year .       establish optimal treatment protocols.
                                                      18
         Therefore, we believe that PRP treatment           This  study  has its  limitations.  A  drawback is
         should also be offered to patients with longer     the  absence of  randomization  and placebo
         lasting dysfunction. In addition, our results      arm in research with few patients. We
         showed only mild or no procedural discomfort       acknowledge that a control group would be
         (VAS  score  ≤  2)  in  all  patients.  Nevertheless,   ideal for determining PRP effectiveness and
         in our experience, despite being reasonably        ruling out the placebo effect. It should also
         painless, the fear of anticipation makes it        be noted that our PRP process included a low
         impactful  in  some  patients.  Hence,  instead    dose of sodium citrate as an anticoagulant
         of using an empirical cycle of three separate      for  PRP  purification.  Sodium  citrate  has
         injections within 2-week intervals , we prefer     been proven to have good platelet recovery
                                           10
         to perform only one injection with ulterior re-    and mesenchymal stromal cell proliferation
         assessment.                                        compared to other anticoagulants, making
         This work also unveiled a peculiar mismatch        it an ideal anticoagulant. However, some
         between the VAS and OPT scores at 1 and            research suggests that sodium citrate can
         3 months, since the correlation between            itself ameliorate olfactory impairment in
         objective and subjective measurements was          postinfectious olfactory loss . In this way,
                                                                                          25
         only  significant  at  baseline.  This  had  been   there might be a synergic effect of PRP when
         previously observed in our pCIOD medical           combined with sodium citrate yielding a 3- to
         treatment  protocol   and  was  somewhat           5-fold increase in growth factor production .
                              1
                                                                                                         9
         described in the PRP pilot study . Analyzing       Thus,  this  fact  could  have  influenced  the
                                            9
         Figure 4, one can note that a more substantial     results.  Also,  for  convenience,  only  OPT  was
         VAS score improvement was reached at the 3         measured in the psychophysical domain, so
         months assessment. This may reflect the delay      that  identification  and  discrimination  were
         between the peripheral neuronal regeneration       not evaluated in this sample. Also, in order
         and central cortical integration. Alternatively, it   to homogenize the sample,  only pCIOD
         may imply that an individual's everyday smell      patients were included, although the initial
         dysfunction experience has subtleties that our     pilot  study  of  PRP  injection  included  other
         olfactory test battery cannot fully capture.       etiologies of olfactory dysfunction . Our study
                                                                                              9
         PRP is being used more frequently in many          has its own strengths as well. It is the first to
         other    surgical   specialties .  Concerning      describe an effective single-site PRP injection
                                       19
         Otorhinolaryngology,    PRP    application   is    protocol applied to olfactory dysfunction.
         not limited to the olfactory science, as it has    Also, it describes therapeutic efficacy of PRP
         previously  been  suggested  as  beneficial  in    injection in patients suffering from pCIOD for
         nasal surgery  20–22 , otology  and cleft palate   ≥ 12 months.
                                    23
         surgery . The exact mechanisms of how
                 24
         PRP may improve olfactory function are             Conclusion
         not fully understood. Some suggest that            We comprehensively described a new single-
         the high concentration of platelet derived         site  PRP injection  protocol  for olfactory
         molecules may stimulate the regeneration           dysfunction management. The olfactory
         of olfactory neurons, improve the function         outcomes of such intervention on pCIOD
         of the olfactory epithelium and halt the           patients were explored. In line with very



     352  Revista Portuguesa de Otorrinolaringologia - Cirurgia de Cabeça e Pescoço
   9   10   11   12   13   14   15   16   17   18   19